City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Anthony Stein, MD  
Search results:  6  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-6 Trials Jump to page:

COH Protocol Number: 14012 ClinicalTrials.gov Number: NCT02094794

Principal Investigator: Anthony Stein, MD
Sponsor: Institutional

Title:  Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination with Cyclophosphamide and Etoposide as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with High-Risk Acute Lymphocytic or Myelogenous Leukemia

COH Protocol Number: 13474 ClinicalTrials.gov Number: NCT02113982

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  SL-401 in Patients with Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

COH Protocol Number: 13330 ClinicalTrials.gov Number: NCT02000427

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE® Antibody Blinatumomab in Adult Subjects with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia (Alcantara Study)

COH Protocol Number: 13175 ClinicalTrials.gov Number: NCT01902329

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase I Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia

COH Protocol Number: 13167 ClinicalTrials.gov Number: NCT01363297

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  An Open-Label, Phase 1/2 Study of Inotuzumab Ozogamicin in Subjects With Relapsed or Refractory CD22-Positive Acute Lymphocytic Leukemia

COH Protocol Number: 11206 ClinicalTrials.gov Number: NCT01466179

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

 
Results per page: 25 50 100 All 1-6 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.